Back to Results
First PageMeta Content
Health / Karolinska Institutet / Karolinska University Hospital / Sweden


1st ACCORD WITH INDUSTRY: Exploring points of mutual interest to globalize and expedite knowledge on rare diseases and orphan medicinal products[removed]Welcome and Introduction - Désirée Gavhed, ICORD Secretariat,
Add to Reading List

Document Date: 2014-06-10 15:20:46

Open Document

File Size: 318,40 KB

Share Result on Facebook

City

SLADIMER / Stockholm / /

Company

Celgene / AstraZeneca / ICORD / /

Country

Belgium / France / Argentina / Sweden / /

Facility

Karolinska University Hospital / /

IndustryTerm

research-based pharmaceutical industry / treatment of common diseases / medicinal products / /

MedicalCondition

Local rare disease / rare diseases / rare disease / common diseases / /

Organization

Karolinska University Hospital / ICORD Secretariat / Karolinska Institutet / /

Person

Laura Gutierrez / Emilio Roldán / Anders Ekblom / Virginia Llera / Karolina Antonov / Jan-Inge Henter / /

Position

Board Member / CEO / Professor / President / Director of Research and Education / Executive Vice President Global Drug Development / ICORD President / /

Technology

Drug Development / /

SocialTag